Authors:
Masago, R
Aiba-Masago, S
Talal, N
Zuluaga, FJ
Al-Hashimi, I
Moody, M
Lau, CA
Peck, AB
Brayer, J
Humphreys-Beher, MG
Dang, H
Citation: R. Masago et al., Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjogren's syndrome, ARTH RHEUM, 44(3), 2001, pp. 693-702
Citation: Dd. Simmons et al., Effect of xerostomic medications on stimulated salivary flow rate in patients with Sjogren's syndrome, QUINTES INT, 31(3), 2000, pp. 196-200
Citation: Mm. Zipp et al., The effect of parotid salivary flow rate on the levels of salivary antimicrobial proteins in patients with Sjogren's syndrome, QUINTES INT, 30(10), 1999, pp. 700-705
Citation: N. Haghighat et I. Al-hashimi, A pilot study on the effect of radiation on calmodulin in rat submandibular salivary glands, ARCH ORAL B, 44(5), 1999, pp. 383-389
Authors:
Vivino, FB
Al-Hashimi, I
Khan, Z
LeVeque, FG
Salisbury, PL
Tran-Johnson, TK
Muscoplat, CC
Trivedi, M
Goldlust, B
Gallagher, SC
Citation: Fb. Vivino et al., Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms inpatients with Sjogren syndrome - A randomized, placebo-controlled, fixed-dose, multicenter trial, ARCH IN MED, 159(2), 1999, pp. 174-181